Related Experiment Video
Updated: Jul 5, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
Ching-Yu Lin1, Angel Chao, Yuh-Cheng Yang
1School of Medical Laboratory Science and Biotechnology, Taipei Medical University, Taipei, Taiwan.
Summary
This study shows the HPV Blot assay accurately detects and types human papillomavirus (HPV) in cervical samples, demonstrating excellent agreement with type-specific PCR for HPV detection and genotyping.
Area of Science:
- Molecular diagnostics
- Oncology
- Virology
Background:
- Persistent human papillomavirus (HPV) infection is a known precursor to invasive cervical cancer.
- Accurate HPV detection and genotyping are crucial for cervical cancer prevention strategies.
Purpose of the Study:
- To assess the effectiveness of a novel polymerase chain reaction (PCR)-based genotyping array for HPV detection and typing.
- To compare the performance of this array against established type-specific PCR methods.
Main Methods:
- Utilized a modified MY11/GP6+ PCR-based reverse-blot assay (HPV Blot) on 433 cervical samples.
- Compared HPV Blot results with 20 L1-type-specific PCR assays for HPV genotyping.
Main Results:
- The HPV Blot demonstrated excellent agreement with type-specific PCR for HPV positivity (concordance 96.8%, Cohen's kappa=0.93).
- Overall type-specific HPV concordance was high at 91.0%.
- The assay showed satisfactory sensitivity, specificity, and accuracy for most HPV types, with excellent kappa values for HPV-16, -52, and -58.
Conclusions:
- The modified MY11/GP6+ PCR-based HPV Blot assay is a reliable tool for detecting and genotyping HPV in cervical samples.
- This assay offers accurate and sensitive performance, supporting its clinical utility in cervical cancer screening.
